Therapy with pamidronate in children with osteogenesis imperfecta

@inproceedings{Mrginean2017TherapyWP,
  title={Therapy with pamidronate in children with osteogenesis imperfecta},
  author={Otilia Mărginean and Raluca Corina Tamasanu and Niculina Mang and Ioana Mozoș and Giorgiana Flavia Brad},
  booktitle={Drug design, development and therapy},
  year={2017}
}
Osteogenesis imperfecta (OI) is a genetic disease characterized by excessive bone fragility with fractures consecutive to minor trauma. Considering lack of standardization of therapy with pamidronate in children, it was our aim to present our experience over a period of 10 years regarding evolution and treatment in patients diagnosed with osteoporosis and OI. Nine patients diagnosed with OI were admitted to the First Pediatric Clinic, Timisoara. They were investigated (clinical, biomarkers of… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

homepage on the Internet

OI Foundatio
  • Available from: http:// www.oif.org/site/PageServer?pagename=oif_mc_home_page. Accessed February
  • 2017
VIEW 1 EXCERPT

webpage on the Internet

M Ramachandran, H Gellman, P Achan
  • Osteogenesis Imperfecta. Available from: http://emedicine.medscape. com/article/1256726-overview. Accessed February
  • 2017
VIEW 1 EXCERPT

Managing osteoporosis patients after long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research

RA Adler, GEH Fuleihan, CD Bauer
  • J Bone Miner Res
  • 2016
VIEW 1 EXCERPT

The Section on Endocrinology. Clinical report from the American Academy of Pediatrics – Bone Densitometry in Children and Adolescents. Pediatrics

LK GABachrach, IN Sills
  • 2011

Similar Papers

Loading similar papers…